# Reach Neuro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reach-neuro

- Industry: Medical Devices & Equipment
- Headquarters: Pittsburgh, US
- Website: www.reachneuro.com
- Latest round: Seed (Dec 17, 2021)
- Investors on record: 1

## About

Based in Pennsylvania, US, and co-founded in 2021 by Marc Powell, Marco Caprogrosso, Douglas Weber, and Peter Gerszten, Reach Neuro Inc. provides a device for patients with post-stroke paralysis. As of 2022, the company has begun its first-in-human clinical trials that proved the effectiveness of its therapy. In December 2021, Reach Neuro Inc. raised Seed funding from the investor SOSV. The company was also awarded a grant from NIH for over USD 8 million to continue clinical trials.

Reach Neuro's team of co-founders and researchers have patented hardware and software devices designed to be implanted into the spine and enable the patient to voluntarily control movement in their arm and hand. The company's treatment is applicable both at the patient's home and in the clinic during physical therapy sessions. From clinical trials, the treatment was shown to increase strength and mobility during physical therapy and improve domestic activities for patients, such as dressing, eating, and bathing.

The company generates revenue by manufacturing medical devices that restore movement in people with post-stroke paralysis and other neurological disorders. 

The company intends to attract Angel Investors to further develop its technology for widespread use. They are also continuing clinical trials using the grant they received from NIH.

## Funding rounds

- Seed, Dec 17, 2021 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed